Naresh Tondare
Head – India and Nepal Regulatory Affairs
Glenmark Pharmaceuticals
B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai – 400 026.
http://www.glenmarkpharma.com/
12 years’ experience in Regulatory Affairs (India, India and Bhutan) and Global Clinical Regulatory Affairs (EU, ROWand India). Responsible for generic, branded generic and NCE products.
Responsible and accountable for Global CMC Regulatory Affairs (India, Nepal, Bhutan, Bangladesh and ROW markets), Global Clinical Regulatory Affairs (EU, US, ROW and India) and Regulatory Intelligence/strategy. Products include Complex Generics, Frist Generics, Generics, Novel Fixed Dose combinations (FDCs) New Drugs (India), Consumer Healthcare, OTC and New Chemical Entity (NCEs).
- This specialized division empowers patients with neurological disorders to reclaim their mobility through a…
SSI Mantra Robotic System performs a successful urology procedure on a one-year-old infant with a…
Ghaziabad, April 22, 2024: In order to strengthen the safety and wellbeing of people, Manipal Hospital…
DKMS EMPHASIZES ITS COMMITMENT TO BLOOD CANCER RESEARCH, SUPPORTS YOUNG SCIENTISTS, AND RECOGNIZES OUTSTANDING RESEARCH…
Dr. Reddy's has launched Nerivio® in Germany through its step-down subsidiary betapharm To be followed…
Hyderabad, April 13, 2024: Ankura Hospital for Women and Children is proud to announce a remarkable medical…